Evidence map›Paper›PMID 32132889›Full record

ArticleFrontiers in neuroscience2020

Metabolic, Molecular, and Behavioral Effects of Western Diet in Serotonin Transporter-Deficient Mice: Rescue by Heterozygosity?

Ekaterina Veniaminova, Raymond Cespuglio, Irina Chernukha, Angelika G Schmitt-Boehrer, Sergey Morozov, Allan V Kalueff, Oxana Kuznetsova, Daniel C Anthony, Klaus-Peter Lesch, Tatyana Strekalova

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neuroscience, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.0field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Novel Antidepressant-Like Properties of the Iron Chelator Deferiprone in a Mouse Model of Depression.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 6 countries.

Ekaterina VeniaminovaDepartment of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, Netherlands.
Raymond CespuglioLaboratory of Psychiatric Neurobiology, Institute of Molecular Medicine, Sechenov First Moscow State Medical University, Moscow, Russia.
Irina ChernukhaV.M. Gorbatov Federal Research Center for Food Systems of RAS, Moscow, Russia.
Angelika G Schmitt-BoehrerDivision of Molecular Psychiatry, Center of Mental Health, University of Würzburg, Würzburg, Germany.
Sergey MorozovInstitute of General Pathology and Pathophysiology, Moscow, Russia.
Allan V KalueffSchool of Pharmacy, Southwest University, Chongqing, China.
Oxana KuznetsovaV.M. Gorbatov Federal Research Center for Food Systems of RAS, Moscow, Russia.
Daniel C AnthonyLaboratory of Psychiatric Neurobiology, Institute of Molecular Medicine, Sechenov First Moscow State Medical University, Moscow, Russia.
Klaus-Peter LeschDepartment of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, Netherlands.
Tatyana StrekalovaDepartment of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, Netherlands.
All-Russian Scientific Research Institute of Refrigeration Industry · RUMaastricht University · NLUniversity of Würzburg · DECentre de Recherche en Neurosciences de Lyon · FRResearch Institute of General Pathology and Pathophysiology, the Russian Academy of Medical Sciences · RUSechenov University · RUSt Petersburg University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Reduced function of the serotonin transporter (SERT) is associated with increased susceptibility to anxiety and depression and with type-2 diabetes, which is especially true in older women. Preference for a "Western diet" (WD), enriched with saturated fat, cholesterol, and sugars, may aggravate these conditions. In previous studies, decreased glucose tolerance, central and peripheral inflammation, dyslipidemia, emotional, cognitive, and social abnormalities were reported in WD-fed young female mice. We investigated the metabolic, molecular, and behavioral changes associated with a 3-week-long dietary regime of either the WD or control diet in 12-month-old female mice with three different

Indexed as

agingglucose toleranceheterosisobesityserotonin receptorsSert-deficient miceToll-like receptor 4 (TLR4)Western diet

Identifiers

PMID32132889
PMCPMC7041415
OpenAlexW3008239507

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.